These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7200827)

  • 1. A phase II evaluation of adriamycin and cis-platinum in hormone resistant prostate cancer.
    Citrin DL; Hogan TF
    Cancer; 1982 Jul; 50(2):201-6. PubMed ID: 7200827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of metastatic prostate cancer. An analysis of response criteria in patients with measurable soft tissue disease.
    Citrin DL; Elson P; DeWys WD
    Cancer; 1984 Jul; 54(1):13-7. PubMed ID: 6372984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant adriamycin and cis-diamminedichloroplatinum (cis-platinum) in primary osteosarcoma.
    Ettinger LJ; Douglass HO; Higby DJ; Mindell ER; Nime F; Ghoorah J; Freeman AI
    Cancer; 1981 Jan; 47(2):248-54. PubMed ID: 6936069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cyclophosphamide, adriamycin, and cis-platinum (CAP) in patients with disseminated prostatic carcinoma. A phase II study.
    Drelichman A; Oldford J; Al-Sarraf M
    Am J Clin Oncol; 1985 Jun; 8(3):255-9. PubMed ID: 3840326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative clinical trial of adriamycin and 5-fluorouracil in advanced prostatic cancer: prognostic factors and response.
    DeWys WD; Begg CB; Brodovsky H; Creech R; Khandekar J
    Prostate; 1983; 4(1):1-11. PubMed ID: 6340081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of cyclophosphamide, adriamycin, cis-platinum, and methotrexate in advanced transitional cell carcinoma of the urinary tract.
    Citrin DL; Hogan TF; Davis TE
    Cancer; 1983 Jan; 51(1):1-4. PubMed ID: 6681590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer: evaluation of response to treatment, response criteria, and the need for standardization of the reporting of results.
    Aabo K
    Eur J Cancer Clin Oncol; 1987 Feb; 23(2):231-6. PubMed ID: 3327696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclophosphamide, adriamycin and cisplatinum combination chemotherapy for advanced urothelial and prostatic carcinoma].
    Tsukamoto T; Tanoguchi H; Nakazono M; Murai M; Tachibana M; Deguchi N; Baba S; Hata M; Jitsukawa S; Tazaki H
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3259-64. PubMed ID: 3688891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of combination chemotherapy with fluorouracil (F), doxorubicin (A), and cisplatin (P) (Fap) in hormonally resistant metastatic prostatic adenocarcinoma.
    Lupera H; Droz JP; Piot G; Lapleige P; Fargeot P; Theodore C
    Oncology; 1989; 46(6):372-4. PubMed ID: 2587004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II evaluation of weekly cisplatin in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group Trial.
    Moore MR; Troner MB; DeSimone P; Birch R; Irwin L
    Cancer Treat Rep; 1986 Apr; 70(4):541-2. PubMed ID: 3698053
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer.
    Ellerhorst JA; Tu SM; Amato RJ; Finn L; Millikan RE; Pagliaro LC; Jackson A; Logothetis CJ
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2371-6. PubMed ID: 9815636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weekly low-dose adriamycin in hormone-resistant metastatic cancer of the prostate.
    Fosså SD; Urnes T; Kaalhus O
    Scand J Urol Nephrol; 1987; 21(1):13-6. PubMed ID: 2438753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of ovarian cancer with a combination of cis-platinum, adriamycin, cyclophosphamide and hexamethylmelamine.
    Razis DV; Poulakou E; Petounis A; Papadimitriou G; Kosmides P; Delides G
    Oncology; 1982; 39(4):205-8. PubMed ID: 6806735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate.
    Papandreou CN; Daliani DD; Thall PF; Tu SM; Wang X; Reyes A; Troncoso P; Logothetis CJ
    J Clin Oncol; 2002 Jul; 20(14):3072-80. PubMed ID: 12118020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin in advanced hormone refractory prostatic cancer patients.
    Canobbio L; Guarneri D; Miglietta L; Decensi A; Oneto F; Boccardo F
    Eur J Cancer; 1993; 29A(15):2094-6. PubMed ID: 7507687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy for medullary cancer of the thyroid. Phase II trials with adriamycin and cis-platinum administered as monochemotherapy].
    Droz JP; Rougier P; Goddefroy V; Schlumberger M; Gardet P; Parmentier C
    Bull Cancer; 1984; 71(3):195-9. PubMed ID: 6541515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic treatment of advanced prostatic cancer: development of a new system for defining response.
    Citrin DL; Cohen AI; Harberg J; Schlise S; Hougen C; Benson R
    J Urol; 1981 Feb; 125(2):224-7. PubMed ID: 6259376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer.
    Citrin DL; Kies MS; Wallemark CB; Khandekar J; Kaplan E; Camacho F; Lind R
    Cancer; 1985 Aug; 56(3):457-60. PubMed ID: 4005808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination of adriamycin and cis-diammine-dichloro-platinum (II) in the treatment of advanced, therapy-resistant, ovarian carcinoma (author's transl)].
    Cavalli F; Stoller U; Tschopp L; Sonntag RW; Brunner KW
    Dtsch Med Wochenschr; 1978 Jun; 103(22):927-31. PubMed ID: 350534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.